Engineered Immune Cells Show Promise for Pulmonary Fibrosis

Published on: Signal Transduction and Targeted Therapy (Nature)

A new study demonstrates how engineered immune cells can be programmed to target and remodel fibrotic lung tissue, offering hope for patients with pulmonary fibrosis. Researchers showed that these modified cells actively reversed fibrosis in preclinical models, paving the way for novel cell-based treatments for chronic and currently incurable lung diseases.

👉 Read the full article: Engineered Immune Cells for Pulmonary Fibrosis

Disclaimer:

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link.